
Gilead Sciences, Inc. (GILD)
Total Dividends
40 dividends distributed from 2015 to 2025
Dividend Change
+83.72% over 10 years
About
Gilead Sciences, Inc. is a biopharmaceutical company founded in 1987, headquartered in Foster City, California. It's known for its research and development in antiviral drugs, particularly those used in the treatment of HIV, hepatitis B, hepatitis C, and influenza. Gilead played a significant role during the COVID-19 pandemic with its antiviral medication, remdesivir. As of now, the CEO is Daniel O’Day, who took the helm in 2019. The company is widely recognized for its innovative approach in tackling complex health challenges and aims to improve patient care worldwide. In 2022, Gilead's revenue was approximately $27 billion, reflecting its strong market presence and the critical nature of its therapies.
Previous Payouts 40
Last payout: $0.79 on March 28, 2025
Pay Date | Amount |
---|---|
March 28, 2025 | $0.79 |
December 30, 2024 | $0.77 |
September 27, 2024 | $0.77 |
June 27, 2024 | $0.77 |
March 28, 2024 | $0.77 |
December 28, 2023 | $0.75 |
September 28, 2023 | $0.75 |
June 29, 2023 | $0.75 |
March 30, 2023 | $0.75 |
December 29, 2022 | $0.73 |
September 29, 2022 | $0.73 |
June 29, 2022 | $0.73 |
March 30, 2022 | $0.73 |
December 30, 2021 | $0.71 |
September 29, 2021 | $0.71 |
June 29, 2021 | $0.71 |
March 30, 2021 | $0.71 |
December 30, 2020 | $0.68 |
September 29, 2020 | $0.68 |
June 29, 2020 | $0.68 |
March 30, 2020 | $0.68 |
December 30, 2019 | $0.63 |
September 27, 2019 | $0.63 |
June 27, 2019 | $0.63 |
March 28, 2019 | $0.63 |
December 28, 2018 | $0.57 |
September 27, 2018 | $0.57 |
June 28, 2018 | $0.57 |
March 29, 2018 | $0.57 |
December 28, 2017 | $0.52 |
September 28, 2017 | $0.52 |
June 29, 2017 | $0.52 |
March 30, 2017 | $0.52 |
December 29, 2016 | $0.47 |
September 29, 2016 | $0.47 |
June 29, 2016 | $0.47 |
March 30, 2016 | $0.43 |
December 30, 2015 | $0.43 |
September 29, 2015 | $0.43 |
June 29, 2015 | $0.43 |
Data last updated: Thu, 03 Apr 2025 21:40:47 GMT